Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters











Publication year range
1.
Liver Transpl ; 26(12): 1629-1643, 2020 12.
Article in English | MEDLINE | ID: mdl-32810371

ABSTRACT

Orthotopic liver transplantation continues to be the only effective therapy for patients with end-stage liver disease. Unfortunately, many of these patients are not considered transplant candidates, lacking effective therapeutic options that would address both the irreversible progression of their hepatic failure and the control of their portal hypertension. In this prospective study, a swine model was exploited to induce subacute liver failure. Autologous hepatocytes, isolated from the left hepatic lobe, were transplanted into the mesenteric lymph nodes (LNs) by direct cell injection. At 30-60 days after transplantation, hepatocyte engraftment in LNs was successfully identified in all transplanted animals with the degree of ectopic liver mass detected being proportional to the induced native liver injury. These ectopic livers developed within the LNs showed remarkable histologic features of swine hepatic lobules, including the formation of sinusoids and bile ducts. On the basis of our previous tyrosinemic mouse model and the present pig models of induced subacute liver failure, the generation of auxiliary liver tissue using the LNs as hepatocyte engraftment sites represents a potential therapeutic approach to supplement declining hepatic function in the treatment of liver disease.


Subject(s)
Liver Transplantation , Animals , Hepatocytes , Humans , Liver/surgery , Liver Transplantation/adverse effects , Lymph Nodes/surgery , Mice , Prospective Studies , Swine
2.
Am J Transplant ; 18(6): 1351-1359, 2018 06.
Article in English | MEDLINE | ID: mdl-29338127

ABSTRACT

Tissue decellularization produces a three-dimensional scaffold that can be used to fabricate functional liver grafts following recellularization. Inappropriate cell distribution and clotting during blood perfusion hinder the practical use of recellularized livers. Here we aimed to establish a seeding method for the optimal distribution of parenchymal and endothelial cells, and to evaluate the effect of liver sinusoidal endothelial cells (LSECs) in the decellularized liver. Primary rat hepatocytes and LSECs were seeded into decellularized whole-liver scaffolds via the biliary duct and portal vein, respectively. Biliary duct seeding provided appropriate hepatocyte distribution into the parenchymal space, and portal vein-seeded LSECs simultaneously lined the portal lumen, thereby maintaining function and morphology. Hepatocytes co-seeded with LSECs retained their function compared with those seeded alone. Platelet deposition was significantly decreased and hepatocyte viability was maintained in the co-seeded group after extracorporeal blood perfusion. In conclusion, our seeding method provided optimal cell distribution into the parenchyma and vasculature according to the three-dimensional structure of the decellularized liver. LSECs maintained hepatic function, and supported hepatocyte viability under blood perfusion in the engineered liver graft owing to their antithrombogenicity. This recellularization procedure could help produce practical liver grafts with blood perfusion.


Subject(s)
Hepatocytes/cytology , Liver Transplantation , Perfusion , Animals , Blood , Cells, Cultured , Endothelial Cells/cytology , Liver/cytology , Liver/physiology , Male , Rats , Rats, Inbred Lew , Rats, Transgenic
3.
J Hepatol ; 68(4): 744-753, 2018 04.
Article in English | MEDLINE | ID: mdl-29288124

ABSTRACT

BACKGROUND & AIMS: Since the first account of the myth of Prometheus, the amazing regenerative capacity of the liver has fascinated researchers because of its enormous medical potential. Liver regeneration is promoted by multiple types of liver cells, including hepatocytes and liver non-parenchymal cells (NPCs), through complex intercellular signaling. However, the mechanism of liver organogenesis, especially the role of adult hepatocytes at ectopic sites, remains unknown. In this study, we demonstrate that hepatocytes alone spurred liver organogenesis to form an organ-sized complex 3D liver that exhibited native liver architecture and functions in the kidneys of mice. METHODS: Isolated hepatocytes were transplanted under the kidney capsule of monocrotaline (MCT) and partial hepatectomy (PHx)-treated mice. To determine the origin of NPCs in neo-livers, hepatocytes were transplanted into MCT/PHx-treated green fluorescent protein transgenic mice or wild-type mice transplanted with bone marrow cells isolated from green fluorescent protein-mice. RESULTS: Hepatocytes engrafted at the subrenal space of mice underwent continuous growth in response to a chronic hepatic injury in the native liver. More than 1.5 years later, whole organ-sized liver tissues with greater mass than those of the injured native liver had formed. Most remarkably, we revealed that at least three types of NPCs with similar phenotypic features to the liver NPCs were recruited from the host tissues including bone marrow. The neo-livers in the kidney exhibited liver-specific functions and architectures, including sinusoidal vascular systems, zonal heterogeneity, and emergence of bile duct cells. Furthermore, the neo-livers successfully rescued the mice with lethal liver injury. CONCLUSION: Our data clearly show that adult hepatocytes play a leading role as organizer cells in liver organogenesis at ectopic sites via NPC recruitment. LAY SUMMARY: The role of adult hepatocytes at ectopic locations has not been clarified. In this study, we demonstrated that engrafted hepatocytes in the kidney proliferated, recruited non-parenchymal cells from host tissues including bone marrow, and finally created an organ-sized, complex liver system that exhibited liver-specific architectures and functions. Our results revealed previously undescribed functions of hepatocytes to direct liver organogenesis through non-parenchymal cell recruitment and organize multiple cell types into a complex 3D liver at ectopic sites. Transcript profiling: Microarray data are deposited in GEO (GEO accession: GSE99141).


Subject(s)
Hepatocytes/physiology , Kidney/cytology , Liver/embryology , Organogenesis , Animals , Cell Movement , Cell Proliferation , Hepatocytes/transplantation , Liver Regeneration , Mice , Mice, Inbred C57BL
4.
Sci Rep ; 7: 44498, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28295042

ABSTRACT

Somatic cells can be reprogrammed to induced hepatocyte-like cells (iHeps) by overexpressing certain defined factors in direct reprogramming techniques. Of the various methods to deliver genes into cells, typically used genome-integrating viral vectors are associated with integration-related adverse events such as mutagenesis, whereas non-integrating viral vectors have low efficiency, making viral vectors unsuitable for clinical application. Therefore, we focused on developing a transposon system to establish a non-viral reprogramming method. Transposons are unique DNA elements that can be integrated into and removed from chromosomes. PiggyBac, a type of transposon, has high transduction efficiency and cargo capacity, and the integrated transgene can be precisely excised in the presence of transposase. This feature enables the piggyBac vector to achieve efficient transgene expression and a transgene-free state, thus making it a promising method for cell reprogramming. Here, we attempted to utilize the piggyBac transposon system to generate iHeps by integrating a transgene consisting of Hnf4a and Foxa3, and successfully obtained functional iHeps. We then demonstrated removal of the transgene to obtain transgene-free iHeps, which still maintained hepatocyte functions. This non-viral, transgene-free reprogramming method using the piggyBac vector may facilitate clinical applications of iHeps in upcoming cell therapy.


Subject(s)
Cellular Reprogramming/genetics , DNA Transposable Elements/genetics , Genetic Vectors , Hepatocytes/metabolism , Gene Transfer Techniques , Humans , Transgenes/genetics , Transposases/genetics
5.
Sci Rep ; 6: 35887, 2016 10 21.
Article in English | MEDLINE | ID: mdl-27767181

ABSTRACT

A whole-organ regeneration approach, using a decellularised xenogeneic liver as a scaffold for the construction of a transplantable liver was recently reported. Deriving suitable scaffolds was the first step towards clinical application; however, effective recellularisation remains to be achieved. This report presents a strategy for the improvement of the recellularisation process, using novel cell-seeding technique and cell source. We evaluated recellularised liver grafts repopulated through the portal vein or the biliary duct with mice adult hepatocytes or E14.5 foetal hepatocytes. More than 80% of the cells seeded through the biliary tree entered the parenchyma beyond the ductule-lining matrix barrier and distributed throughout the liver lobule. In contrast, about 20% of the cells seeded through the portal tree entered the parenchyma. The gene expression levels of foetal hepatocyte albumin, glucose 6-phosphatase, transferrin, cytokeratin 19, and gamma-glutamyl transpeptidase were increased in three-dimensional cultures in the native liver-derived scaffolds, and the activation of liver detoxification enzymes and formation of biliary duct-like structures were supported. The metabolic functions of liver grafts recellularised with different cell types were similar. These results suggest that biliary tree cell-seeding approach is promising, and that liver progenitor cells represent a good cell source candidate.


Subject(s)
Bile Ducts/transplantation , Hepatocytes/transplantation , Liver Regeneration/physiology , Liver/cytology , Animals , Bile Ducts/cytology , Bile Ducts/metabolism , Cell Culture Techniques , Cells, Cultured , Fetus/cytology , Glucose-6-Phosphatase/metabolism , Hepatocytes/cytology , Hepatocytes/metabolism , Keratin-19/metabolism , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Microscopy, Fluorescence , Parenchymal Tissue/metabolism , Parenchymal Tissue/pathology , Rats , Rats, Inbred Lew , Tissue Scaffolds , Transferrins/metabolism , Transplantation, Heterologous , gamma-Glutamyltransferase/metabolism
6.
Sci Rep ; 6: 30489, 2016 07 26.
Article in English | MEDLINE | ID: mdl-27457505

ABSTRACT

The current lack of cancer stem cell (CSC) markers that are easily evaluated by blood samples prevents the establishment of new therapeutic strategies in hepatocellular carcinoma (HCC). Herein, we examined whether sex determining region Y-box 9 (SOX9) represents a new CSC marker, and whether osteopontin (OPN) can be used as a surrogate marker of SOX9 in HCC. In HCC cell lines transfected with a SOX9 promoter-driven enhanced green fluorescence protein gene, FACS-isolated SOX9(+) cells were capable of self-renewal and differentiation into SOX9(-) cells, and displayed high proliferation capacity in vitro. Xenotransplantation experiments revealed that SOX9(+) cells reproduced, differentiated into SOX9(-) cells, and generated tumors at a high frequency in vivo. Moreover, SOX9(+) cells were found to be involved in epithelial-mesenchymal transition (EMT) and activation of TGFb/Smad signaling. Gain/loss of function experiments showed that SOX9 regulates Wnt/beta-catenin signaling, including cyclin D1 and OPN. Immunohistochemistry of 166 HCC surgical specimens and serum OPN measurements showed that compared to SOX9(-) patients, SOX9(+) patients had significantly poorer recurrence-free survival, stronger venous invasion, and higher serum OPN levels. In conclusion, SOX9 is a novel HCC-CSC marker regulating the Wnt/beta-catenin pathway and its downstream target, OPN. OPN is a useful surrogate marker of SOX9 in HCC.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , Neoplastic Stem Cells/metabolism , Osteopontin/metabolism , SOX9 Transcription Factor/metabolism , Animals , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/surgery , Cell Line, Tumor , Epithelial-Mesenchymal Transition , Green Fluorescent Proteins/metabolism , Humans , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Mice, SCID , Multivariate Analysis , Phenotype , Prognosis , Smad Proteins/metabolism , Transforming Growth Factor beta/metabolism , Wnt Signaling Pathway , Xenograft Model Antitumor Assays
7.
BMC Surg ; 15: 128, 2015 Dec 18.
Article in English | MEDLINE | ID: mdl-26680600

ABSTRACT

BACKGROUND: Incisional surgical site infection (SSI) is one of the most frequent complications that occur after colorectal surgery. Surgery for colorectal perforation carries an especially high risk of incisional SSI because fecal ascites contaminates the incision intraoperatively, and in patients who underwent stoma creation, the incision is located near the infective origin and is subject to infection postoperatively. Although effectiveness of the preventive SSI bundle of elective colorectal surgery has been reported, no study has focused exclusively on emergency surgery for colorectal perforation. METHODS: Patients with colorectal perforation who underwent emergency surgery and stoma creation from 2010 to 2015 at our center were consecutively enrolled in the study. In March 2013, we developed the preventive incisional SSI bundle for patients with colorectal perforation undergoing stoma creation. The effectiveness of the bundle in these patients was determined and the rates of incisional SSI between before and after March 2013 were compared. RESULTS: We enrolled 108 patients with colorectal perforation who underwent emergency operation during the study period. Thirteen patients were excluded because they died within 30 days after surgery, and 23 patients without stoma were excluded; thus, 72 patients were analyzed. There were 47 patients in the pre-implementation group and 25 patients in the post-implementation group. The rate of incisional SSI was significantly lower after implementation of preventive incisional SSI bundle (43% vs. 20%, p = 0.049). Postoperative hospital stay was significantly shorter after implementation of the bundle (27 vs. 18 days respectively; p = 0.008). CONCLUSIONS: The preventive incisional SSI bundle was effective in preventing incisional SSI in patients with colorectal perforation undergoing emergency surgery with stoma creation.


Subject(s)
Colonic Diseases/surgery , Intestinal Perforation/surgery , Rectal Diseases/surgery , Surgical Wound Infection/etiology , Surgical Wound Infection/prevention & control , Aged , Aged, 80 and over , Antibiotic Prophylaxis , Digestive System Surgical Procedures/adverse effects , Digestive System Surgical Procedures/methods , Female , Humans , Length of Stay , Male , Middle Aged , Retrospective Studies , Suture Techniques , Therapeutic Irrigation , Tissue Adhesives/therapeutic use
8.
World J Emerg Surg ; 10: 24, 2015.
Article in English | MEDLINE | ID: mdl-26213564

ABSTRACT

INTRODUCTION: Even after surgery and intensive postoperative management, the mortality rate associated with colorectal perforation is high. Identification of mortality markers using routinely available preoperative parameters is important. METHODS: We enrolled consecutive patients with colorectal perforation who underwent operations from January 2010 to January 2015. We divided them into a mortality and survivor group and compared clinical characteristics between the two groups. Additionally, we compared the mortality rate between different etiologies: malignant versus benign and diverticular versus nondiverticular. We used the χ (2) and Mann-Whitney U tests and a logistic regression model to identify factors associated with mortality. RESULTS: We enrolled 108 patients, and 52 (48 %) were male. The mean age at surgery was 71 ± 13 years. The postoperative mortality rate was 12 % (13 patients). Multivariate logistic regression analysis showed that a high patient age (odds ratio [OR], 1.09; 95 % confidence interval [CI], 1.020-1.181) and low preoperative systolic blood pressure (OR, 0.98; 95 % CI, 0.953-0.999) were independent risk factors for mortality in patients with colorectal perforation. In the subgroup analysis, there was no significant difference between the malignant and benign group (11.8 % vs. 23.9 %, respectively; p = 0.970), while the diverticular group had a significantly lower mortality rate than the nondiverticular group (2.6 % vs. 17.1 %, respectively; p = 0.027). CONCLUSIONS: Older patients and patients with low preoperative blood pressure had a high risk of mortality associated with colorectal perforation. For such patients, operations and postoperative management should be performed carefully.

9.
Curr Opin Organ Transplant ; 19(2): 169-74, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24480968

ABSTRACT

PURPOSE OF REVIEW: This review outlines the concept of cell-based therapy to restore tissue function, and addresses four key points to consider in cell transplantation: source, surveillance, safety, and site. Whereas each point is essential, additional attention should be given to transplantation sites if cell therapy is going to be successful in the clinic. Various ectopic locations are discussed, and the strengths and weaknesses of each are compared as suitable candidates for cell therapy. RECENT FINDINGS: Studies in rodents often demonstrate cell transplantation and engraftment in ectopic sites, with little evidence to suggest why it may also work in humans. For example, transplantation to the subcapsular space of the kidney is often performed in rodents, but has not been a good predictor of clinical success. Recent work has shown that the lymph node may be a good site for transplantation of multiple tissue types, and several reasons are highlighted as to why it should be considered for future studies. SUMMARY: The use of cell-based therapy in the clinic has been hampered by the lack of appropriate sites for transplantation. The lymph node is a promising alternative for cell transplantation, and offers hope for clinical application.


Subject(s)
Cell Transplantation , Cell- and Tissue-Based Therapy , Organ Specificity , Stem Cell Transplantation , Animals , Cell Transplantation/methods , Cell- and Tissue-Based Therapy/methods , Choristoma , Humans , Lymph Nodes/cytology , Organogenesis , Regenerative Medicine
10.
Cell Transplant ; 23(12): 1537-44, 2014.
Article in English | MEDLINE | ID: mdl-23998208

ABSTRACT

Primary human fetal and adult hepatocytes have been considered feasible donor cell sources for cell transplantation. We compared the engraftment efficiencies between adult human, fetal human, and adult porcine hepatocytes after transplantation into MUP-uPA(tg(+/+))Rag2(-/-)γC(-/-)mice. Transplantation of adult human hepatocytes yielded a 1,000-fold higher serum albumin level compared to transplantation of fetal human hepatocytes, while transplantation of adult porcine hepatocytes resulted in a 100-fold higher serum albumin level than adult human hepatocytes. These results suggest that adult liver cells are superior to fetal liver cells for transplantation, and caution should be applied if porcine hepatocytes are used for preclinical studies as a proof of concept for human hepatocytes.


Subject(s)
DNA-Binding Proteins/deficiency , Hepatocytes/transplantation , Interleukin Receptor Common gamma Subunit/deficiency , Proteins/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Adult , Animals , DNA-Binding Proteins/metabolism , Humans , Interleukin Receptor Common gamma Subunit/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Sus scrofa , Transplantation, Heterologous
11.
Int J Cancer ; 134(5): 1067-76, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-23959426

ABSTRACT

Activation-induced cytidine deaminase (AID) contributes to inflammation-associated carcinogenesis through its mutagenic activity. In our study, by taking advantage of the ability of AID to induce genetic aberrations, we investigated whether liver cancer originates from hepatic stem/progenitor cells that accumulate stepwise genetic alterations. For this purpose, hepatic progenitor cells enriched from the fetal liver of AID transgenic (Tg) mice were transplanted into recipient "toxin-receptor mediated conditional cell knockout" (TRECK) mice, which have enhanced liver regeneration activity under the condition of diphtheria toxin treatment. Whole exome sequencing was used to determine the landscape of the accumulated genetic alterations in the transplanted progenitor cells during tumorigenesis. Liver tumors developed in 7 of 11 (63.6%) recipient TRECK mice receiving enriched hepatic progenitor cells from AID Tg mice, while no tumorigenesis was observed in TRECK mice receiving hepatic progenitor cells of wild-type mice. Histologic examination revealed that the tumors showed characteristics of hepatocellular carcinoma and partial features of cholangiocarcinoma with expression of the AID transgene. Whole exome sequencing revealed that several dozen genes acquired single nucleotide variants in tumor tissues originating from the transplanted hepatic progenitor cells of AID Tg mice. Microarray analyses revealed that the majority of the mutations (>80%) were present in actively transcribed genes in the liver-lineage cells. These findings provided the evidence suggesting that accumulation of genetic alterations in fetal hepatic progenitor cells progressed to liver cancers, and the selection of mutagenesis depends on active transcription in the liver-lineage cells.


Subject(s)
Cytidine Deaminase/physiology , Liver Neoplasms, Experimental/etiology , Liver/cytology , Stem Cells/physiology , Animals , Cell Transformation, Neoplastic , Cytidine Deaminase/genetics , Diphtheria Toxin/pharmacology , Mice , Mice, Transgenic
12.
Nat Biotechnol ; 30(10): 976-83, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23000933

ABSTRACT

Cell-based therapy has been viewed as a promising alternative to organ transplantation, but cell transplantation aimed at organ repair is not always possible. Here we show that the mouse lymph node can support the engraftment and growth of healthy cells from multiple tissues. Direct injection of hepatocytes into a single mouse lymph node generated enough ectopic liver mass to rescue the survival of mice with lethal metabolic disease. Furthermore, thymuses transplanted into single lymph nodes of athymic nude mice generated functional immune systems that were capable of rejecting allogeneic and xenogeneic grafts. Additionally, pancreatic islets injected into the lymph nodes of diabetic mice restored normal glucose control. Collectively, these results suggest the practical approach of targeting lymph nodes to restore, maintain or improve tissue and organ functions.


Subject(s)
Hepatocytes/transplantation , Islets of Langerhans Transplantation , Lymph Nodes/physiology , Organ Specificity , Animals , Choristoma/pathology , Diabetes Mellitus, Experimental/therapy , Green Fluorescent Proteins/metabolism , Injections , Islets of Langerhans/physiology , Liver/physiology , Lymph Nodes/blood supply , Mice , Mice, Inbred C57BL , Mice, Transgenic , Thymus Gland/physiology , Thymus Gland/transplantation
13.
Hepatology ; 54(5): 1830-41, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21793026

ABSTRACT

UNLABELLED: The identification of resident stem cells in the mouse gallbladder is, to date, unexplored. In addition, the relationship between adult gallbladder stem cells and intrahepatic bile duct (IHBD) cells is not well understood. The aim of this study was to isolate stem cells from an adult mouse gallbladder and determine whether they were unique, compared to IHBD cells. By limiting dilution analyses and index sorts, we found that an EpCAM(+) CD49f(hi) epithelial cell subpopulation from primary gallbladder is enriched in colony-forming cells, compared to EpCAM(+) CD49f(lo) cells. EpCAM(+) CD49f(hi) cells expressed cluster of differentiation (CD)29, CD133, and stem cell antigen-1, but were negative for lineage markers CD31, CD45, and F4/80. Using a novel feeder cell-culture system, we observed long-term (>passage 20) and clonal expansion of the EpCAM(+) CD49f(hi) cells in vitro. In a matrigel differentiation assay, EpCAM(+) CD49f(+) cells expanding in vitro underwent organotypic morphogenesis forming ductular structures and cysts. These structures are similar to, and recapitulate a transport function of, primary gallbladder. EpCAM(+) CD49f(+) cells also engraft into the subcutaneous space of recipient mice. We compared primary gallbladder and IHBD cells by flow cytometry and found phenotypic differences in the expression of CD49f, CD49e, CD81, CD26, CD54, and CD166. In addition, oligonucleotide microarrays showed that the expanded EpCAM(+) CD49f(+) gallbladder cells and IHBD cells exhibit differences related to lipid and drug metabolism. Notable genes that were different are cytochrome P450, glutathione S-transferase, Indian hedgehog, and solute carrier family genes. CONCLUSION: We have isolated an epithelial cell population from primary mouse gallbladder with stem cell characteristics and found it to be unique, compared to IHBD cells.


Subject(s)
Adult Stem Cells/cytology , Gallbladder/cytology , Stem Cell Niche/physiology , Adult Stem Cells/metabolism , Age Factors , Animals , Antigens, Neoplasm/metabolism , Bile Ducts, Intrahepatic/cytology , Biomarkers/metabolism , Cell Adhesion Molecules/metabolism , Cell Differentiation/physiology , Cell Separation/methods , Cells, Cultured , Epithelial Cell Adhesion Molecule , Epithelial Cells/cytology , Epithelial Cells/metabolism , Green Fluorescent Proteins/genetics , Integrin alpha6/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phenotype
14.
Tissue Eng Part C Methods ; 17(6): 677-86, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21375407

ABSTRACT

BACKGROUND & AIMS: The therapy of choice for end-stage liver disease is whole-organ liver transplantation, but this option is limited by a shortage of donor organs. Cell-based therapies and hepatic tissue engineering have been considered as alternatives to liver transplantation, but neither has proven effective to date. A regenerative medicine approach for liver replacement has recently been described that includes the use of a three-dimensional organ scaffold prepared by decellularization of xenogeneic liver. The present study investigates a new, minimally disruptive method for whole-organ liver decellularization and three different cell reseeding strategies to engineer functional liver tissue. METHODS: A combination of enzymatic, detergent, and mechanical methods are used to remove all cells from isolated rat livers. Whole-organ perfusion is used in a customized organ chamber and the decellularized livers are examined by morphologic, biochemical, and immunolabeling techniques for preservation of the native matrix architecture and composition. Three different methods for hepatocyte seeding of the resultant three-dimensional liver scaffolds are evaluated to maximize cell survival and function: (1) direct parenchymal injection, (2) multistep infusion, or (3) continuous perfusion. RESULTS: The decellularization process preserves the three-dimensional macrostructure, the ultrastructure, the composition of the extracellular matrix components, the native microvascular network of the liver, and the bile drainage system, and up to 50% of growth factor content. The three-dimensional liver matrix reseeded with the multistep infusion of hepatocytes generated ∼90% of cell engraftment and supported liver-specific functional capacities of the engrafted cells, including albumin production, urea metabolism, and cytochrome P450 induction. CONCLUSIONS: Whole-organ liver decellularization is possible with maintenance of structure and composition suitable to support functional hepatocytes.


Subject(s)
Hepatocytes/cytology , Hepatocytes/transplantation , Liver, Artificial , Organ Culture Techniques/methods , Tissue Scaffolds , Animals , Cell Differentiation , Cells, Cultured , Hepatocytes/physiology , Male , Mice , Mice, Inbred C57BL , Prosthesis Design , Rats , Rats, Sprague-Dawley
15.
Gastroenterology ; 140(2): 656-666.e2, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21070777

ABSTRACT

BACKGROUND & AIMS: Hepatocyte transplantation is a potential therapeutic approach for liver disease. However, most patients with chronic hepatic damage have cirrhosis and fibrosis, which limit the potential for cell-based therapy of the liver. The development of an ectopic liver as an additional site of hepatic function represents a new approach for patients with end-stage liver disease. We investigated the development and function of liver tissue in lymph nodes in mice with liver failure. METHODS: Hepatocytes were isolated from 8- to 12-week-old mice and transplanted by intraperitoneal injection into 8- to 12-week-old fumarylacetoacetate hydrolase mice (Fah(-/-)), a model of the human liver disease tyrosinemia type I. Survival was monitored and the locations and functions of the engrafted liver cells were determined. RESULTS: Lymph nodes of Fah(-/-) mice were colonized by transplanted hepatocytes; Fah(+) hepatocytes were detected adjacent to the CD45(+) lymphoid cells of the lymphatic system. Ten weeks after transplantation, these mice had substantial improvements in serum levels of transaminases, bilirubin, and amino acids. Homeostatic expansion of donor hepatocytes in lymph nodes rescued the mice from lethal hepatic failure. CONCLUSIONS: Functional ectopic liver tissue in lymph nodes rescues mice from lethal hepatic disease; lymph nodes therefore might be used as sites for hepatocyte transplantation.


Subject(s)
Hepatocytes/transplantation , Liver Failure/surgery , Lymph Nodes/physiology , Amino Acids/blood , Animals , Bilirubin/blood , Chronic Disease , Disease Models, Animal , Female , Hydrolases/genetics , Leukocyte Common Antigens/analysis , Liver Failure/etiology , Lymphocytes/physiology , Male , Mice , Mice, Inbred C57BL , Transaminases/blood , Tyrosinemias/complications , Tyrosinemias/genetics , Tyrosinemias/surgery
16.
Hepatology ; 47(3): 888-96, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18306229

ABSTRACT

UNLABELLED: Chronic inflammation plays a critical role in oncogenesis in various human organs. Epidemiological studies have demonstrated that patients with primary sclerosing cholangitis have a predisposition to develop cholangiocarcinoma (CC). However, the molecular mechanisms that account for the development of bile duct carcinomas are not well defined. We recently provided evidence that activation-induced cytidine deaminase (AID), a member of the DNA/RNA editing enzyme family, is implicated in human tumorigenesis via its mutagenic activity. We found here that ectopic AID production is induced in response to tumor necrosis factor-alpha (TNF-alpha) stimulation via the IkappaB kinase-dependent nuclear factor-kappaB (NF-kappaB) activation pathway in human cholangiocarcinoma-derived cells. Aberrant expression of AID in biliary cells resulted in the generation of somatic mutations in tumor-related genes, including p53, c-myc, and the promoter region of the INK4A/p16 sequences. In human tissue specimens, real-time reverse transcription polymerase chain reaction (RT-PCR) analyses revealed that AID was increased significantly in 28 of 30 CC tissues (93%), whereas only trace amounts of AID were detected in the normal liver. Immunohistochemistry showed that all of the CC tissue samples examined showed overproduction of endogenous AID protein in cancer cells. Moreover, immunostaining for AID was detectable in 16 of 20 bile epithelia in the tissues underlying primary sclerosing cholangitis. CONCLUSION: The proinflammatory cytokine-induced aberrant production of AID might link bile duct inflammation to an enhanced genetic susceptibility to mutagenesis, leading to cholangiocarcinogenesis.


Subject(s)
Bile Duct Neoplasms/etiology , Bile Ducts, Intrahepatic , Cholangiocarcinoma/etiology , Cholangitis/complications , Cytidine Deaminase/metabolism , Aged , Bile Duct Neoplasms/enzymology , Bile Duct Neoplasms/pathology , Bile Ducts, Intrahepatic/drug effects , Bile Ducts, Intrahepatic/enzymology , Bile Ducts, Intrahepatic/pathology , Cells, Cultured , Cholangiocarcinoma/enzymology , Cholangiocarcinoma/pathology , Cholangitis/enzymology , Cholangitis/pathology , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cytidine Deaminase/analysis , Cytidine Deaminase/genetics , Cytokines/pharmacology , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Mutagenesis , Mutation , Proto-Oncogene Proteins c-myc/genetics , Tumor Suppressor Protein p53/genetics
17.
Transplantation ; 84(10): 1233-9, 2007 Nov 27.
Article in English | MEDLINE | ID: mdl-18049107

ABSTRACT

BACKGROUND: The use of cell transplantation as an alternative therapy for orthotopic liver transplantation has been widely anticipated due to a chronic donor shortage. We previously reported the method used to enrich hepatic progenitor cells (HPCs) forming cell aggregations. In this study, we transplanted HPCs into the liver injury model mice to determine whether HPC transplantation may improve the liver dysfunction. METHODS: We obtained donor cells from E13.5 fetal livers of green fluorescent protein (GFP) transgenic mice. We transplanted GFP-positive fetal liver cells into the transgenic mice which express diphtheria toxin (DT) receptors under the control of an albumin enhancer/promoter. Subsequently, we induced selective liver injury to recipient mice by DT administration. We then evaluated the engraftment of the transplanted cells and their effect on survivorship. RESULTS: The low dose of DT induced sublethal liver injury and the high dose of DT was lethal to the liver injury model mice. The transplanted GFP-positive cells were engrafted into the recipient livers and expressed albumin, resembling mature hepatocytes. They continued to proliferate, forming clusters. The survival rate at 25 days after transplantation of the cell-transplanted group (8 of 20; 40.0%) was improved significantly (P=0.0047) in comparison to that of the sham-operated group (0 of 20; 0%). CONCLUSIONS: The transplanted cells were engrafted and repopulated the liver of recipient mice, resulting in the improvement of the survival rate of the liver injury model mice. We therefore propose that HPCs are a desirable cell source for cell transplantation.


Subject(s)
Cell Transplantation/methods , Liver Failure/therapy , Liver/cytology , Liver/embryology , Animals , Diphtheria Toxin/toxicity , Disease Models, Animal , Graft Survival , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Heparin-binding EGF-like Growth Factor , Intercellular Signaling Peptides and Proteins/deficiency , Intercellular Signaling Peptides and Proteins/genetics , Liver Failure/chemically induced , Liver Failure/mortality , Mice , Mice, Knockout , Mice, Transgenic
18.
Stem Cells ; 25(12): 3252-60, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17885077

ABSTRACT

ESCs are a potential cell source for cell therapy. However, there is no evidence that cell transplantation using ESC-derived hepatocytes is therapeutically effective. The main objective of this study was to assess the therapeutic efficacy of the transplantation of ESC-derived endodermal cells into a liver injury model. The beta-galactosidase-labeled mouse ESCs were differentiated into alpha-fetoprotein (AFP)-producing endodermal cells. AFP-producing cells or ESCs were transplanted into transgenic mice that expressed diphtheria toxin (DT) receptors under the control of an albumin enhancer/promoter. Selective damage was induced in the recipient hepatocytes by the administration of DT. Although the transplanted AFP-producing cells had repopulated only 3.4% of the total liver mass 7 days after cell transplantation, they replaced 32.8% of the liver by day 35. However, these engrafted cells decreased (18.3% at day 40 and 7.9% at day 50) after the cessation of DT administration, and few donor cells were observed by days 60-90. The survival rate of the AFP-producing cell-transplanted group (66.7%) was significantly higher in comparison with that of the sham-operated group (17.6%). No tumors were detected by day 50 in the AFP-producing cell-transplanted group; however, splenic teratomas did form 60 days or more after transplantation. ESC transplantation had no effect on survival rates; furthermore, there was a high frequency of tumors in the ESC-transplanted group 35 days after transplantation. In conclusion, this study demonstrates, for the first time, that ESC-derived endodermal cells improve the survival rates after transplantation into mice with induced hepatocellular injury. Disclosure of potential conflicts of interest is found at the end of this article.


Subject(s)
Embryonic Stem Cells/transplantation , Endoderm/transplantation , Liver Failure/pathology , Liver Failure/surgery , Stem Cell Transplantation/methods , Animals , Cells, Cultured , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Endoderm/cytology , Endoderm/metabolism , Hepatocytes/cytology , Hepatocytes/physiology , Liver Failure/mortality , Liver Failure/physiopathology , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/pathology , Liver Regeneration/physiology , Mesentery , Mice , Mice, Inbred C57BL , Mice, Transgenic , Peritoneal Neoplasms/etiology , Peritoneal Neoplasms/metabolism , Peritoneal Neoplasms/pathology , Splenic Neoplasms/etiology , Splenic Neoplasms/metabolism , Splenic Neoplasms/pathology , Stem Cell Transplantation/adverse effects , alpha-Fetoproteins/administration & dosage , alpha-Fetoproteins/biosynthesis , alpha-Fetoproteins/genetics
19.
Hepatogastroenterology ; 52(65): 1362-3, 2005.
Article in English | MEDLINE | ID: mdl-16201074

ABSTRACT

Anastomosis between the segment VI intrahepatic bile duct and the stump of the cystic duct was done to relieve obstructive jaundice caused by high biliary malignant obstruction. This procedure is considered to be a safe and easy method to provide good palliation in patients with unresectable hepatic hilar carcinoma.


Subject(s)
Bile Ducts, Intrahepatic/surgery , Cholecystostomy/methods , Cholestasis/surgery , Aged , Anastomosis, Surgical , Cholangiography/methods , Cystic Duct , Female , Humans , Magnetic Resonance Imaging , Palliative Care , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL